Novo Nordisk's pricing strategies while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of selling price gouging, pointing out the stark distinction between U.S. price ranges and people in Europe and copyright.California biotech behemoth Amgen ditched ideas for an experimental weight loss cap